Physician profile
Hans E Bengtson
NPI 1245214212
$3,484.19
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,800 · 2020: $285 · 2021: $1,054 · 2022: $328 · 2023: $17.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,223.15 | 2019-2022 | |
| Si-Bone, INC. | $837.27 | 2019 | |
| Foundation Fusion Solutions, LLC | $498.09 | 2021 | |
| Boston Scientific Corporation | $332.70 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Nevro Corp. | $93.30 | 2019 | |
| Bioventus LLC | $79.70 | 2022 | |
| Collegium Pharmaceutical, INC. | $62.53 | 2019-2022 | |
| Abbvie INC. | $50.69 | 2021-2022 | |
| Spr Therapeutics, INC | $35.79 | 2020 | |
| Redhill Biopharma INC. | $34.80 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $33.29 | 2019-2020 | |
| Amgen INC. | $32.48 | 2019 | |
| Arbor Pharmaceuticals, INC. | $31.03 | 2021 | |
| Novartis Pharmaceuticals Corporation | $25.24 | 2019 | |
| Grt US Holding, INC. | $21.96 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $19.91 | 2022 | |
| Orexo US, INC. | $18.77 | 2019 | |
| Forte Bio-Pharma LLC | $15.45 | 2019 | |
| Pfizer INC. | $13.26 | 2021 | |
| Biodelivery Sciences International, INC. | $12.93 | 2021 | |
| Horizon Therapeutics Plc | $11.85 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hans Bengtson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.